Medication info
PosiCombi Tablet 10/100 Milligrams

PosiCombi Tablet 10/100 Milligrams

Prescription medicationTablet
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.4mg / 1 tabletDapagliflozin citric acid›14.7mg / 1 tablet
Manufacturer / importer
영일제약(주)
Appearance
Yellow, rectangular film-coated tablets
Packaging
28 tablets/box [(7 tablets/PTP x 4)], 30 tablets/box [(10 tablets/PTP x 3)]
Approval status
Active

MFDS item code 202200499 · Approved 2022.01.28 · Insurance code 649405640

Summary

Main use
Improvement in blood sugar control for type 2 diabetes
Who uses it
Adults
Adult dosage
This medication can be administered as 1 tablet once daily without regard to meals for patients taking sitagliptin 100 mg and dapagliflozin 10 mg. The tablet should be swallowed whole.

Ingredients

Manufacturer
영일제약(주)

Efficacy & effects

Improvement in blood sugar control for type 2 diabetes

View approved original text

This medication is prescribed to assist in blood sugar control for patients with type 2 diabetes using a combination of sitagliptin and dapagliflozin. It is effective when used alongside dietary and exercise regimens to support effective blood sugar management. This helps stabilize blood sugar levels and improve diabetes symptoms.

Dosage and Administration

Adult dosage

This medication can be administered as 1 tablet once daily without regard to meals for patients taking sitagliptin 100 mg and dapagliflozin 10 mg. The tablet should be swallowed whole.

Precautions

This medication contains two components that help in blood sugar control and is used for the treatment of diabetes. While taking this medication, allergic reactions may occur, so if symptoms such as rash, itching, or difficulty breathing arise, stop taking it immediately and consult a doctor. There is a risk of developing a serious inflammation of the pancreas called pancreatitis, so if symptoms such as abdominal pain, nausea, or vomiting arise, inform a healthcare provider immediately. This medication is not recommended for patients with certain genetic disorders, type 1 diabetes, diabetic ketoacidosis, or patients undergoing dialysis. Patients with reduced kidney function or the elderly require dosage adjustments and periodic kidney function tests, and should be cautious of the risk of fluid depletion and hypotension. During treatment, the risk of genital and urinary infections may increase, so appropriate treatment should be sought for any infection symptoms. Hypoglycemic symptoms may occur, so blood sugar levels should be monitored carefully, especially when taken with other hypoglycemic agents such as insulin or sulfonylureas. It is advised that pregnant or breastfeeding women do not use this medication, and it should be discontinued immediately if pregnancy is confirmed. The elderly are at higher risk of decreased kidney function, so regular kidney function tests are necessary, and dosage adjustments should be made with caution. In case of overdose, there is no specific antidote, so treatment should be symptomatic and in accordance with healthcare provider instructions. There is generally no significant effect of this medication when taken alone on driving or operating machinery, but caution is necessary due to the risk of hypoglycemia when used with other hypoglycemic agents. The safety and efficacy of this medication have not been established in children, so it is not recommended for individuals under 18 years of age. Store the medication in its original container and keep it out of reach of children.

Side effects and when to seek care immediately

Serious side effects

  • Hives
  • severe swelling (edema)
  • chest tightness
  • difficulty breathing
  • cold sweat
  • pallor
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • exfoliative dermatitis
Show 15 more
  • acute pancreatitis
  • acute renal failure
  • worsening kidney function
  • ketoacidosis
  • diabetic ketoacidosis
  • urosepsis
  • pyelonephritis
  • severe rash
  • blisters
  • skin peeling
  • pain in mucous membranes of mouth/eyes
  • severe allergic reactions
  • severe skin adverse reactions
  • respiratory issues
  • liver abnormalities

Mild side effects

Hypoglycemia, dizziness, constipation, dry mouth, back pain, polyuria, nocturia, vulvar itching, genital itching, increased hematocrit, decreased renal creatinine clearance at the beginning of treatment, dyslipidemia, elevated serum creatinine, elevated blood urea, weight loss, upper respiratory infection, nasopharyngitis, headache, diarrhea, nausea, abdominal pain, vomiting, dyspepsia, vertigo, palpitations, insomnia, tinnitus, menstrual irregularities, vaginal discharge, itching

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is best stored at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain its effectiveness.

Appearance and packaging

Appearance

Yellow, rectangular film-coated tablets

Package unit

28 tablets/box [(7 tablets/PTP x 4)], 30 tablets/box [(10 tablets/PTP x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.